| Product Code: ETC7290514 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Georgia PCR-based Infectious Diseases Market Overview |
3.1 Georgia Country Macro Economic Indicators |
3.2 Georgia PCR-based Infectious Diseases Market Revenues & Volume, 2021 & 2031F |
3.3 Georgia PCR-based Infectious Diseases Market - Industry Life Cycle |
3.4 Georgia PCR-based Infectious Diseases Market - Porter's Five Forces |
3.5 Georgia PCR-based Infectious Diseases Market Revenues & Volume Share, By Test Type, 2021 & 2031F |
3.6 Georgia PCR-based Infectious Diseases Market Revenues & Volume Share, By Infection, 2021 & 2031F |
3.7 Georgia PCR-based Infectious Diseases Market Revenues & Volume Share, By Pathogen, 2021 & 2031F |
3.8 Georgia PCR-based Infectious Diseases Market Revenues & Volume Share, By PCR Technology, 2021 & 2031F |
3.9 Georgia PCR-based Infectious Diseases Market Revenues & Volume Share, By Patient Type, 2021 & 2031F |
3.10 Georgia PCR-based Infectious Diseases Market Revenues & Volume Share, By Testing, 2021 & 2031F |
3.11 Georgia PCR-based Infectious Diseases Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Georgia PCR-based Infectious Diseases Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in Georgia |
4.2.2 Growing awareness about the benefits of PCR-based testing for infectious diseases |
4.2.3 Technological advancements in PCR testing leading to more accurate and faster results |
4.3 Market Restraints |
4.3.1 High cost associated with PCR-based testing |
4.3.2 Limited access to PCR testing facilities in rural areas of Georgia |
4.3.3 Regulatory challenges and approvals for new PCR testing methods |
5 Georgia PCR-based Infectious Diseases Market Trends |
6 Georgia PCR-based Infectious Diseases Market, By Types |
6.1 Georgia PCR-based Infectious Diseases Market, By Test Type |
6.1.1 Overview and Analysis |
6.1.2 Georgia PCR-based Infectious Diseases Market Revenues & Volume, By Test Type, 2021- 2031F |
6.1.3 Georgia PCR-based Infectious Diseases Market Revenues & Volume, By Tuberculosis PCR Test, 2021- 2031F |
6.1.4 Georgia PCR-based Infectious Diseases Market Revenues & Volume, By Hepatitis PCR Test, 2021- 2031F |
6.1.5 Georgia PCR-based Infectious Diseases Market Revenues & Volume, By Human Immunodeficiency Virus (HIV) PCR Test, 2021- 2031F |
6.1.6 Georgia PCR-based Infectious Diseases Market Revenues & Volume, By Influenza PCR Test, 2021- 2031F |
6.1.7 Georgia PCR-based Infectious Diseases Market Revenues & Volume, By Human Papilloma Virus (HPV) PCR Test, 2021- 2031F |
6.2 Georgia PCR-based Infectious Diseases Market, By Infection |
6.2.1 Overview and Analysis |
6.2.2 Georgia PCR-based Infectious Diseases Market Revenues & Volume, By Viral Infection, 2021- 2031F |
6.2.3 Georgia PCR-based Infectious Diseases Market Revenues & Volume, By Respiratory Tract Infection, 2021- 2031F |
6.2.4 Georgia PCR-based Infectious Diseases Market Revenues & Volume, By Sexually Transmitted Infection, 2021- 2031F |
6.2.5 Georgia PCR-based Infectious Diseases Market Revenues & Volume, By Hospital Acquired Infections, 2021- 2031F |
6.2.6 Georgia PCR-based Infectious Diseases Market Revenues & Volume, By Other Infections, 2021- 2031F |
6.3 Georgia PCR-based Infectious Diseases Market, By Pathogen |
6.3.1 Overview and Analysis |
6.3.2 Georgia PCR-based Infectious Diseases Market Revenues & Volume, By Viral, 2021- 2031F |
6.3.3 Georgia PCR-based Infectious Diseases Market Revenues & Volume, By Bacterial, 2021- 2031F |
6.3.4 Georgia PCR-based Infectious Diseases Market Revenues & Volume, By Fungal, 2021- 2031F |
6.3.5 Georgia PCR-based Infectious Diseases Market Revenues & Volume, By Protozoa, 2021- 2031F |
6.3.6 Georgia PCR-based Infectious Diseases Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Georgia PCR-based Infectious Diseases Market, By PCR Technology |
6.4.1 Overview and Analysis |
6.4.2 Georgia PCR-based Infectious Diseases Market Revenues & Volume, By RT PCR, 2021- 2031F |
6.4.3 Georgia PCR-based Infectious Diseases Market Revenues & Volume, By Multiplex PCR, 2021- 2031F |
6.4.4 Georgia PCR-based Infectious Diseases Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Georgia PCR-based Infectious Diseases Market, By Patient Type |
6.5.1 Overview and Analysis |
6.5.2 Georgia PCR-based Infectious Diseases Market Revenues & Volume, By Geriatric, 2021- 2031F |
6.5.3 Georgia PCR-based Infectious Diseases Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.5.4 Georgia PCR-based Infectious Diseases Market Revenues & Volume, By Adults, 2021- 2031F |
6.6 Georgia PCR-based Infectious Diseases Market, By Testing |
6.6.1 Overview and Analysis |
6.6.2 Georgia PCR-based Infectious Diseases Market Revenues & Volume, By Laboratory Based Testing, 2021- 2031F |
6.6.3 Georgia PCR-based Infectious Diseases Market Revenues & Volume, By Point of Care Testing, 2021- 2031F |
6.7 Georgia PCR-based Infectious Diseases Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 Georgia PCR-based Infectious Diseases Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F |
6.7.3 Georgia PCR-based Infectious Diseases Market Revenues & Volume, By Hospital, 2021- 2031F |
6.7.4 Georgia PCR-based Infectious Diseases Market Revenues & Volume, By Community Health Centers, 2021- 2031F |
6.7.5 Georgia PCR-based Infectious Diseases Market Revenues & Volume, By Community Health Centers, 2021- 2031F |
6.7.6 Georgia PCR-based Infectious Diseases Market Revenues & Volume, By Clinics, 2021- 2031F |
6.7.7 Georgia PCR-based Infectious Diseases Market Revenues & Volume, By Home Healthcare, 2021- 2031F |
7 Georgia PCR-based Infectious Diseases Market Import-Export Trade Statistics |
7.1 Georgia PCR-based Infectious Diseases Market Export to Major Countries |
7.2 Georgia PCR-based Infectious Diseases Market Imports from Major Countries |
8 Georgia PCR-based Infectious Diseases Market Key Performance Indicators |
8.1 Average turnaround time for PCR test results |
8.2 Number of PCR testing facilities in Georgia |
8.3 Percentage of healthcare professionals trained in PCR testing techniques |
9 Georgia PCR-based Infectious Diseases Market - Opportunity Assessment |
9.1 Georgia PCR-based Infectious Diseases Market Opportunity Assessment, By Test Type, 2021 & 2031F |
9.2 Georgia PCR-based Infectious Diseases Market Opportunity Assessment, By Infection, 2021 & 2031F |
9.3 Georgia PCR-based Infectious Diseases Market Opportunity Assessment, By Pathogen, 2021 & 2031F |
9.4 Georgia PCR-based Infectious Diseases Market Opportunity Assessment, By PCR Technology, 2021 & 2031F |
9.5 Georgia PCR-based Infectious Diseases Market Opportunity Assessment, By Patient Type, 2021 & 2031F |
9.6 Georgia PCR-based Infectious Diseases Market Opportunity Assessment, By Testing, 2021 & 2031F |
9.7 Georgia PCR-based Infectious Diseases Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Georgia PCR-based Infectious Diseases Market - Competitive Landscape |
10.1 Georgia PCR-based Infectious Diseases Market Revenue Share, By Companies, 2024 |
10.2 Georgia PCR-based Infectious Diseases Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here